Anika announces regulatory approval for MONOVISC(R) in Australia for treatment of pain
Anika Therapeutics announced that regulatory authorities in Australia granted approval to MONOVISC®, Anika's single injection viscosupplement for the treatment of pain associated with osteoarthritis of all synovial joints, including the hip and knee. October 16, 2017